RIO DE JANEIRO (Reuters) - Preliminary studies suggest the AstraZeneca vaccine will protect against the P1 variant of the coronavirus, Mauricio Zuma, the head of production at Brazil’s Fiocruz biomedical institute said on Monday, confirming a Reuters report on Friday. The Brazil variant is worrying experts because it is highly contagious and has led several countries to ban travel from the Latin American nation.